• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of interferon related gene regulation as a proapoptotic function against hepatocellular carcinoma

Research Project

Project/Area Number 15590650
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionOkayama University

Principal Investigator

SAKAGUCHI Kohsaku  Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Associate Professor, 大学院・医歯薬学総合研究科, 助教授 (90235143)

Co-Investigator(Kenkyū-buntansha) TAKAKI Akinobu  Okayama University, University Hospital of Medicine and Dentistry, Assistant, 医学部・歯学部附属病院, 助手 (80359885)
SHIRATORI Yasushi  Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Professor, 大学院・医歯薬学総合研究科, 教授 (70196624)
Project Period (FY) 2003 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2005: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2004: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2003: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsInterferon / Caspase / signal transduction / hepatocellular carcinoma / アポトーシス / 5-FU / マイクロアレイ
Research Abstract

Interferon (IFN) combined with 5-Fluorouracil (5-FU) treatment is recently reported to show marked effects in patients with advanced hepatocellular carcinoma (HCC). IFN alpha 2 is widely provided for chronic liver diseases. But IFN alpha 8 is the most effective subtype to induce apoptosis in several cancer cell lines. In this study, we investigated the molecular mechanisms of apoptosis induction in hepatoma cell lines with IFN alpha 2 or alpha 8 in combination with 5-FU. Five hepatoma cell lines (Hep3B, Huh7, HLE, PLC/PRL/5, and HepG2) were tested for apoptosis inducibility by IFN alpha in the absence or presence of 5-FU. Hep3B was the most apoptosis sensitive to IFN plus 5-FU treatment. Caspases-3, -9, and especially caspase-8 activities were higher with IFN alpha plus 5-FU than IFN or 5-FU alone. The JAK-STAT pathway transcriptional factor ISRE was activated more synergistically when 5-FU was added to both IFN alpha treatments. Inhibition of caspase-3,-8,9,c-Jun N-terminal kinase (JNK), phosphatidylinositide 3-kinase (PI3K), and p38 mitogen-activated protein kinase (p38 MAPK) revealed that caspase-8 inhibition was the most effective treatment to decrease apoptotic effects of IFN and/or 5-FU. In JAK1, and ISGF3g-silenced Hep3B cells, the apoptosis induction and caspase-8 activation levels by IFN, even in combination with 5-FU, were abrogated. Although IFN alpha 8 induced apoptosis more effectively than alpha 2 and showed different cluster in microarray analysis, the JAK-STAT and caspase activation status were similar.
We conclude that caspase-8 is the most important factor that controls IFN-and 5-FU- induced apoptosis in hepatoma cell lines.

Report

(4 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • 2003 Annual Research Report
  • Research Products

    (17 results)

All 2006 2005 2004 Other

All Journal Article (13 results) Publications (4 results)

  • [Journal Article] 肝細胞癌の予防はできるか?-一次予防と二次予防の試みと成績-2006

    • Author(s)
      坂口孝作, 白鳥康史
    • Journal Title

      Medical Practice 23

      Pages: 82-85

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Development of hepatocellular carcinoma in a woman with HBV- and HCV- negative autoimmune hepatitis with unsatisfactory response to Corticosteroid.2005

    • Author(s)
      Miyake Y, Sakaguchi K, et al.
    • Journal Title

      Intern Med 44

      Pages: 949-953

    • NAID

      130000076311

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.2005

    • Author(s)
      Tanaka H, Sakaguchi K, et al.
    • Journal Title

      J Gastroenterol Hepatol. 20

      Pages: 850-856

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Development of hepatocellular carcinoma in a woman with HBV- and HCV- negative autoimmune hepatitis with unsatisfactory response to Corticosteroid.2005

    • Author(s)
      Miyake Y, Sakaguchi K, et al.
    • Journal Title

      Intern Med. 44

      Pages: 949-953

    • NAID

      130000076311

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.2005

    • Author(s)
      Tanaka H, Sakaguchi K, Shiratori Y, et al.
    • Journal Title

      J Gastroenterol Hepatol 20(6)

      Pages: 850-856

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Development of hepatocellular carcinoma in a woman with HBV- and HCV-negative autoimmune hepatitis with unsatisfactory response to corticosteroid.2005

    • Author(s)
      Miyake Y, Sakaguchi K, Shiratori Y, et al.
    • Journal Title

      Intern Med 44(9)

      Pages: 949-953

    • NAID

      130000076311

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Risk factors for hepatocellular carcinoma in fepatitis C patients with sustained virologic response to interferon therapy.2004

    • Author(s)
      Iwasaki Y, Sakaguchi K, et al.
    • Journal Title

      Liver Int. 24

      Pages: 603-610

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] 岡山大学病院において 特集ウイルス肝炎と肝移植III.施設における現状と対策 : 内科医より2004

    • Author(s)
      高木章乃夫, 坂口孝作他
    • Journal Title

      今日の移植 18

      Pages: 213-215

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] C型肝細胞癌の根治療法後の再発率と予後,ウイルス性肝炎(上)-基礎・臨床の進歩-2004

    • Author(s)
      坂口孝作, 白鳥康史他
    • Journal Title

      日本臨床 62

      Pages: 629-633

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Risk factors for hepatocellular carcinoma in hepatitis C patients with sustained virologic response to interferon therapy.2004

    • Author(s)
      Iwasaki Y, Sakaguchi K, et al.
    • Journal Title

      Liver Int. 24

      Pages: 603-610

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] 5-FU and IFN alpha8 combination treatment induce more severe apoptosis and caspase activities than 5-FU and IFN alpha2 treatment in hepatoma cell lines2004

    • Author(s)
      Koike K., Takaki A., Sakaguchi K., et al.
    • Journal Title

      Digestive Disease Week

      Pages: 813-813

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 5-FUによる肝癌細胞株アポトーシス誘導に対するインターフェロンα2とα8の増強効果の違いはcaspase活性化と関係する2004

    • Author(s)
      小池和子, 高木章乃夫, 坂口孝作 他
    • Journal Title

      肝臓 45(1)

    • Related Report
      2004 Annual Research Report
  • [Journal Article] インターフェロンα8はα2よりもcaspaseを強く活性化し、抗癌剤による肝細胞癌株アポトーシスを誘導する2004

    • Author(s)
      小池和子, 高木章乃夫, 坂口孝作 他
    • Journal Title

      肝臓 45(2)

    • Related Report
      2004 Annual Research Report
  • [Publications] 高木 章乃夫他: "インターフェロンαサブタイプによる肝癌細胞アポトーシス誘導能の相違"日本消化器病学会雑誌. 100Suppl. A150 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 高木 章乃夫, 坂口 孝作他: "インターフェロンαサブタイプによる肝癌細胞アポトーシス誘導能の相違と、細胞内情報伝達系及びアポトーシス関連遺伝子の変化の関連"肝臓. 44Suppl(1). A168 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 小池 和子, 高木章乃夫他: "5FUによる肝細胞癌株アポトーシス誘導に対するインターフェロンαの増強効果はサプタイプにより異なる"肝臓. 44Suppl(2). A410 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Akinobu Takaki, Kohsaku Sakaguchi, et al.: "Interferon alpha 8 and 2 show differential activation of apoptosis and growth factor pathway in human hepatoma cell lines"Hepatology. 38Suppl.1. 406A (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi